SCHEMBL16453522

SCHEMBL16453522

Cc1ccnc(OCCC2CCCC2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.48
NPC1 O15118 1/20 0.48
TP53 P04637 1/20 0.48
TSHR P16473 1/20 0.48
RAB9A P51151 1/20 0.48
KMT2A Q03164 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
NFE2L2 Q16236 1/20 0.43
ALDH1A1 P00352 2/20 0.42
KDM4E B2RXH2 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
LOX P28300 1/20 0.39
LOXL2 Q9Y4K0 1/20 0.39
ALOX5 P09917 3/20 0.39
PPARG P37231 2/20 0.39
CRHR1 P34998 1/20 0.39
PTGES O14684 1/20 0.38
PTGS2 P35354 1/20 0.38
PSEN1 P49768 1/20 0.38
FFAR1 O14842 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16453456 0.98 NPC1 (0.50) MEN1NPC1TP53TSHRRAB9A
SCHEMBL16453463 0.94 CRHR1 (0.43) MEN1NPC1TP53TSHRRAB9A
SCHEMBL426634 0.85 CTSL (0.41) MEN1NPC1TP53TSHRRAB9A
SCHEMBL16453454 0.84 KDM4E (0.44) MEN1NPC1TP53TSHRRAB9A
SCHEMBL16453504 0.83 KDM4E (0.46) MEN1NPC1TP53TSHRRAB9A
SCHEMBL16450593 0.82 NFE2L2 (0.41) MEN1NPC1TP53TSHRRAB9A
SCHEMBL16453526 0.81 LOX (0.46) MEN1NPC1TP53TSHRRAB9A
SCHEMBL16450598 0.81 NFE2L2 (0.43) MEN1NPC1TP53TSHRRAB9A
SCHEMBL19955139 0.80 NFE2L2 (0.46) MEN1NPC1TP53TSHRRAB9A
SCHEMBL26157152 0.79 TLR9 (0.39) FFAR1ACACB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150045357-A1 SMALL MOLECULE INHIBITORS OF MCL-1 AND USES THEREOF THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2015-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150045357-A1 SMALL MOLECULE INHIBITORS OF MCL-1 AND USES THEREOF MCL1, BCL2L1, BCL3 MEN1 281/4885NPC1 1906/4885TP53 33/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.